CGC
Price
$8.70
Change
-$0.27 (-3.01%)
Updated
Apr 25, 6:59 PM EST
CRON
Price
$2.50
Change
+$0.02 (+0.81%)
Updated
Apr 25, 6:59 PM EST
11 days until earnings call
Ad is loading...

CGC vs CRON ᐉ Comparison: Which is Better to Invest?

Header iconCGC vs CRON Comparison
Open Charts CGC vs CRONBanner chart's image
Canopy Growth
Price$8.70
Change-$0.27 (-3.01%)
Volume$2.54M
CapitalizationN/A
Cronos Group
Price$2.50
Change+$0.02 (+0.81%)
Volume$881.51K
CapitalizationN/A
View a ticker or compare two or three
CGC vs CRON Comparison Chart

Loading...

CGCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CRONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CGC vs. CRON commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and CRON is a Buy.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (CGC: $8.97 vs. CRON: $2.48)
Brand notoriety: CGC: Notable vs. CRON: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 51% vs. CRON: 76%
Market capitalization -- CGC: $784.64M vs. CRON: $1B
CGC [@Pharmaceuticals: Other] is valued at $784.64M. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileCRON’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • CRON’s FA Score: 1 green, 4 red.
According to our system of comparison, CRON is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while CRON’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 6 bearish.
  • CRON’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRON is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а +38.21% price change this week, while CRON (@Pharmaceuticals: Other) price change was +2.48% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.10%. For the same industry, the average monthly price growth was +25.87%, and the average quarterly price growth was +18903.10%.

Reported Earning Dates

CGC is expected to report earnings on Feb 09, 2024.

CRON is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (-2.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for CGC with price predictions.
OPEN
A.I.dvisor published
a Summary for CRON with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRON($1.01B) has a higher market cap than CGC($785M). CGC YTD gains are higher at: 75.538 vs. CRON (18.660). CRON has higher annual earnings (EBITDA): -71.8M vs. CGC (-1.02B). CRON has more cash in the bank: 862M vs. CGC (186M). CRON has less debt than CGC: CRON (2.55M) vs CGC (693M). CGC has higher revenues than CRON: CGC (362M) vs CRON (87.2M).
CGCCRONCGC / CRON
Capitalization785M1.01B78%
EBITDA-1.02B-71.8M1,424%
Gain YTD75.53818.660405%
P/E RatioN/AN/A-
Revenue362M87.2M415%
Total Cash186M862M22%
Total Debt693M2.55M27,145%
FUNDAMENTALS RATINGS
CGC vs CRON: Fundamental Ratings
CGC
CRON
OUTLOOK RATING
1..100
7058
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
3540
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (72) in the Pharmaceuticals Other industry is in the same range as CGC (94) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CRON's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as CGC (99) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew similarly to CGC’s over the last 12 months.

CGC's Price Growth Rating (35) in the Agricultural Commodities Or Milling industry is in the same range as CRON (40) in the Pharmaceuticals Other industry. This means that CGC’s stock grew similarly to CRON’s over the last 12 months.

CRON's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that CRON’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCCRON
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
CGCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CRONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WAFMX3.230.04
+1.25%
Wasatch Frontier Emerg Sm Countrs Inv
BMSFX14.270.01
+0.07%
MFS Blended Research Mid Cap Eq A
MAICX7.95N/A
N/A
Victory Trivalent Intl Fd-Core Eq A
PLCGX18.60-0.02
-0.11%
Principal LargeCap Growth I R6
VKSAX18.63-0.05
-0.27%
Virtus KAR Small-Mid Cap Core A

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-0.66%
SNDL - CGC
77%
Closely correlated
-3.38%
ACB - CGC
72%
Closely correlated
-2.96%
CRON - CGC
61%
Loosely correlated
+0.40%
TLRY - CGC
60%
Loosely correlated
N/A
OGI - CGC
50%
Loosely correlated
-1.03%
More

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+0.40%
SNDL - CRON
73%
Closely correlated
-3.38%
CGC - CRON
61%
Loosely correlated
-0.66%
TLRY - CRON
60%
Loosely correlated
N/A
OGI - CRON
58%
Loosely correlated
-1.03%
ACB - CRON
53%
Loosely correlated
-2.96%
More